Segall Bryant & Hamill’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13.7M Sell
1,302,258
-43,272
-3% -$635K 0.18% 194
2026
Q2
$23.6M Sell
1,345,530
-197,880
-13% -$2.61M 0.28% 114
2026
Q1
$25.4M Buy
1,543,410
+348,549
+29% +$8.56M 0.36% 80
2025
Q4
$34.1M Sell
1,194,861
-34,291
-3% -$929K 0.46% 57
2025
Q3
$36.2M Sell
1,229,152
-71,044
-5% -$1.94M 0.48% 51
2025
Q2
$37.5M Buy
1,300,196
+11,478
+0.9% +$339K 0.53% 42
2025
Q1
$45.1M Buy
1,288,718
+242,069
+23% +$9.9M 0.69% 19
2024
Q4
$46.6M Buy
1,046,649
+617,592
+144% +$25.3M 0.64% 28
2024
Q3
$19.6M Buy
+429,057
New +$17.4M 0.27% 119

Other funds holding QDEL

Segall Bryant & Hamill's QDEL Position: Q3 2026 in Review

Segall Bryant & Hamill reduced its QuidelOrtho (QDEL) stake by 3.2% in Q3 2026, selling an estimated $635K and leaving 1,302,258 shares worth $13.7M. The position accounts for 0.18% of the portfolio, ranked #194.

Segall Bryant & Hamill first reported a position in QDEL in Q3 2024 and has held it in 9 quarters since. The position peaked at $46.6M in Q4 2024. 240 funds tracked by Wall St. Rank hold QDEL as of Q3 2026.

  • Segall Bryant & Hamill held 1,302,258 shares of QuidelOrtho worth $13.7M as of Q3 2026.
  • Segall Bryant & Hamill sold 43,272 QuidelOrtho shares in Q3 2026, an estimated $635K.
  • QuidelOrtho made up 0.18% of Segall Bryant & Hamill's portfolio in Q3 2026, its #194 holding.
  • Segall Bryant & Hamill first reported a position in QuidelOrtho in Q3 2024 and has held it in 9 quarters since.
  • Segall Bryant & Hamill's QuidelOrtho position peaked at $46.6M in Q4 2024.
  • 240 funds tracked by Wall St. Rank held QuidelOrtho as of Q3 2026.

Based on Segall Bryant & Hamill's 13F filing for Q3 2026, filed 16 Nov 2026.